Recent Updates
Recently added Catalysts

ReSure Sealant, Sutures

Phase 3

Cataract Surgery Incision Leak | Unknown | Ophthalmology |Ocular Therapeutix, Inc.|Last Updated: Dec 12, 2016

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLED
Total Trials1
Total Enrollment488

FDA Designations

No designations recorded

Clinical trial landscape

ReSure Sealant, Sutures · 1 trial · 1 indication

Phase 3 1
NCT01498224ReSure Sealant Pivotal StudyCataract Surgery Incision Leak
COMPLETED488 Analytics
PHASE3COMPLETED
ReSure Sealant Pivotal Study
Cataract Surgery Incision LeakUnlock trial analytics

Study Endpoints

Primary Endpoints

Proportion of eyes with any clear corneal incision/suture leakage as determined by positive Seidel test indicating fluid egress within first 7 days after surgery.
Days 1-28

Secondary Endpoints

Foreign Body Sensation
Days 1-28
Best corrected visual acuity
Day 1
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingSINGLE
ModelPARALLEL
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
SutureACTIVE_COMPARATORSuture application
ReSure SealantEXPERIMENTALSealant application

Interventions

NameTypeDescription
ReSure SealantDEVICEComparison of ReSure Sealant to suture(s)
SuturesPROCEDURE -
Unlock Study Design Details

Eligibility Criteria

Age Range22 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Subject has a cataract and is expected to undergo clear cornea cataract surgery with phacoemulsification and implantation of posterior chamber intraocular lens * Subject must be 22 years of age or older Exclusion Criteria: * Any intraocular inflammation in study eye or prese...

Countries:United States
Unlock Eligibility Criteria

Frequently asked questions about ReSure Sealant, Sutures

What is ReSure Sealant used for?

ReSure Sealant is a hydrogel sealant used to prevent or manage incision leaks following cataract surgery. It is applied to the corneal incision site to provide a watertight seal, reducing the risk of postoperative leakage and potential complications associated with fluid egress from the eye.

Who makes ReSure Sealant?

ReSure Sealant is developed by Ocular Therapeutix, Inc., a biopharmaceutical company traded on the NASDAQ under the ticker symbol OCUL. The company focuses on therapies for ophthalmic conditions, and ReSure Sealant is one of its key product candidates in the ophthalmology space.

What phase is ReSure Sealant in?

ReSure Sealant is in Phase 3 clinical development. It has completed a pivotal Phase 3 study, and it remains an investigational product. It is not yet approved by regulatory authorities, and its safety and efficacy are still being evaluated through clinical trials.

What clinical trials is ReSure Sealant in?

ReSure Sealant has one completed Phase 3 clinical trial, identified as NCT01498224, titled 'ReSure Sealant Pivotal Study'. This trial enrolled 488 participants in the United States and evaluated the sealant's effectiveness in managing incision leaks during cataract surgery. The study was active-controlled and randomized.

How does ReSure Sealant work?

ReSure Sealant works by forming a hydrogel barrier over the corneal incision site after cataract surgery. This sealant acts as a physical plug to prevent fluid leakage from the eye, thereby maintaining intraocular pressure and promoting proper wound healing. It is designed to be applied topically to the eye.